Abstract Details

Title Interferon Beta-1a (Avonex[reg]) Delays the Onset of Clinically Definite MS over 5 Years of Treatment: Results from CHAMPIONS Study

Topic

Presentation(s)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Valentyna Honchar, MD (Capital Neurology)	No disclosure on file
Michael Dobbs, MD (University of Texas Rio Grande Valley of Medicine)	Dr. Dobbs has received publishing royalties from a publication relating to health care.
Edison Campos, MD (University of Kentucky)	No disclosure on file
Fernando Alarcon, MD (Hospital Eugenio Espejo)	Dr. Alarcon has nothing to disclose.
	No disclosure on file

��ɫ��